Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Disease save search
Adhera Therapeutics Provides Insight on Corporate Strategy, Development of Parkinson’s Disease and Type 1 Diabetes Drugs
Published: 2021-09-13 (Crawled : 15:00) - globenewswire.com
ATRX | $0.0067 12K
|
Manufacturing
| Email alert
Add to watchlist
disease parkinson diabetes drug
Manufacturing Commences on Adhera’s MLR-1019 for Phase 2a Clinical Trial Treating Parkinson’s Disease
Published: 2021-10-15 (Crawled : 15:00) - globenewswire.com
ATRX | $0.0067 12K
|
Manufacturing
|
| O: 10.47%
H: 19.05%
C: 14.29%
disease phase 2 parkinson trial phase 2b
Webinar - Dr Erika Spaeth to interview A/Prof Charles Siles on risk assessment tests for serious disease
Published: 2022-11-10 (Crawled : 14:20) - globenewswire.com
GENE | News 0 d | $2.39 1.6K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -0.45%
disease risk
GeneType's Groundbreaking Saliva Test Transforms Early Disease Detection, Paving the Way for Personalized Wellness
Published: 2023-12-14 (Crawled : 13:00) - globenewswire.com
GENE | News 0 d | $2.39 1.6K
|
Health Technology
|
| O: 1.09%
H: 14.8%
C: 12.56%
disease test saliva wellness
Relief Therapeutics and Acer Therapeutics Announce that the European Commission Has Granted Orphan Drug Designation for ACER-001 in Maple Syrup Urine Disease
Published: 2022-08-12 (Crawled : 13:00) - biospace.com/
RLFTF | $1.45 1.3K
|
n/a
|
| O: 5.71%
H: 2.7%
C: 0.0%
ACER | $0.9 -3.61% 420K
|
Health Technology
|
| O: 1.36%
H: 4.0%
C: -2.0%
acer-001 designation drug disease urine granted therapeutics
Acer Therapeutics and Relief Therapeutics Announce ACER-001 IND Submission for the Treatment of Maple Syrup Urine Disease
Published: 2022-07-28 (Crawled : 13:00) - biospace.com/
RLFTF | $1.45 1.3K
|
n/a
|
| O: 3.08%
H: 0.0%
C: -6.79%
ACER | $0.9 -3.61% 420K
|
Health Technology
|
| O: 0.7%
H: 4.86%
C: -1.39%
acer-001 treatment disease urine therapeutics submission
Relief Therapeutics Recognizes Rare Disease Day and Announces U.S. Availability of New PKU GOLIKE Bars
Published: 2023-02-28 (Crawled : 12:00) - biospace.com/
RLFTF | $1.45 1.3K
|
n/a
|
| O: -13.04%
H: 32.5%
C: 31.5%
day rare disease therapeutics
Relief Announces That Collaboration Partner, Acer Therapeutics, was Issued U.S. Patent 11,202,767 Covering ACER-001 Methods of Use for Treatment of Urea Cycle Disorders and Maple Syrup Urine Disease
Published: 2022-02-01 (Crawled : 09:00) - biospace.com/
RLFTF | $1.45 1.3K
|
n/a
|
| O: -5.33%
H: 5.63%
C: 3.52%
acer-001 urea urine treatment order ces patent therapeutics disease collaboration
Nova Mentis Applauds Government Decision to Create Rare Disease Advisory Group
Published: 2023-11-03 (Crawled : 17:00) - biospace.com/
NMLSF | $0.0117 17K
|
n/a
| Email alert
Add to watchlist
rare disease group
Emmaus Life Sciences Announces Collaboration with Kier (Junior) Spates to Share Personal Experience with Sickle Cell Disease and Endari®
Published: 2022-09-28 (Crawled : 11:00) - prnewswire.com
EMMA | $0.0921 66K
|
Professional, Scientific, and T...
|
| O: 6.67%
H: 25.0%
C: 25.0%
endari sciences disease collaboration life
Sickle Cell Disease Treatment Market to Garner USD 1.6 Billion by 2031: Allied Market Research
Published: 2022-11-10 (Crawled : 01:00) - prnewswire.com
EMMA | $0.0921 66K
|
Professional, Scientific, and T...
|
| O: -18.92%
H: 15.0%
C: 15.0%
NVS | News | $98.03 0.77% 650K
|
Health Technology
|
| O: 2.81%
H: 0.43%
C: -0.2%
treatment research disease market
Emmaus Life Sciences Presents Positive Transfusion Data from a Post-Hoc Analysis of its Phase 3 Clinical Study of Endari® in Patients With Sickle Cell Disease at the 63rd American Society of Hematology (ASH) Annual Meeting
Published: 2021-12-14 (Crawled : 14:30) - biospace.com/
EMMA | $0.0921 66K
|
Professional, Scientific, and T...
|
| O: -0.33%
H: 2.65%
C: -2.65%
endari ema transfusion disease cel positive life science phase 3
Emmaus Life Sciences Presented Positive Real-World Data on the Efficacy of Endari® in Preventing Acute Complications from Sickle Cell Disease at the 62nd Annual Scientific Meeting of the British Society for Haematology
Published: 2022-04-07 (Crawled : 13:00) - biospace.com/
EMMA | $0.0921 66K
|
Professional, Scientific, and T...
|
| O: -2.11%
H: 0.0%
C: -13.98%
endari disease positive
Emmaus Life Sciences Announces Partnership with UpScript to Provide Telehealth Solutions to Sickle Cell Disease Patients
Published: 2021-11-11 (Crawled : 14:15) - prnewswire.com
EMMA | $0.0921 66K
|
Professional, Scientific, and T...
|
| O: -6.98%
H: 8.33%
C: 0.0%
disease partnership life science
Global Market for Stem Cells 2023: Potential as Disease Treatment Options Fuels Market Momentum
Published: 2023-03-28 (Crawled : 22:00) - prnewswire.com
ISCO | News | $0.0712 94.93% 1.8K
|
Manufacturing
|
| O: 0.0%
H: 0.0%
C: -13.16%
BCLI A | $0.535 1.91% 76K
|
Health Technology
|
| O: -1.63%
H: 36.46%
C: 34.81%
disease momentum treatment global potential market
Cell Therapy Market 2022-2026 | Increasing Prevalence of Chronic Diseases to Boost Growth | Technavio
Published: 2022-03-03 (Crawled : 11:00) - prnewswire.com
NVSEF | News | $96.0 52K
|
Health Technology
|
| O: -3.02%
H: 0.0%
C: -0.06%
ALPMY | News | $9.49 480K
|
Manufacturing
|
| O: -1.78%
H: 1.63%
C: 1.5%
NVS | News | $98.03 0.77% 650K
|
Health Technology
|
| O: 0.66%
H: 0.0%
C: 0.0%
BCLI A | $0.535 1.91% 76K
|
Health Technology
|
| O: -0.64%
H: 2.09%
C: -2.25%
disease cel therapy growth
Cell therapy market size to grow by USD 21.061 billion from 2021 to 2026 | Market is driven by the increasing prevalence of chronic disease - Technavio
Published: 2023-10-24 (Crawled : 02:00) - prnewswire.com
ALPMY | News | $9.49 480K
|
Manufacturing
|
| O: -0.4%
H: 1.18%
C: 0.17%
NVS | News | $98.03 0.77% 650K
|
Health Technology
|
| O: -0.17%
H: 1.02%
C: 0.4%
BCLI A | $0.535 1.91% 76K
|
Health Technology
|
| O: -0.3%
H: 6.21%
C: -8.0%
disease cell therapy market
Mallinckrodt Presents Clinical Data for TERLIVAZ® (terlipressin) for Injection in Adults with Hepatorenal Syndrome (HRS) at Digestive Disease Week (DDW) 2023
Published: 2023-05-08 (Crawled : 12:00) - biospace.com/
MNK | $0.3402 -0.06% 540K
|
n/a
|
| O: 3.91%
H: 5.46%
C: 2.82%
terlivaz disease week injection
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets, 2020-2021 & 2026
Published: 2022-04-25 (Crawled : 12:00) - prnewswire.com
ALPMF | News | $9.5 1.2K
|
Health Technology
|
| O: -2.78%
H: 0.0%
C: 0.0%
GLAXF | News | $19.54 2.6K
|
Health Technology
|
| O: -0.99%
H: 0.0%
C: -0.11%
SNYNF | News | $94.25 480
|
Health Technology
|
| O: 0.27%
H: 0.0%
C: 0.0%
MNKKQ | $0.02
|
Manufacturing
|
| O: -2.96%
H: 2.29%
C: -6.57%
ALPMY | News | $9.49 480K
|
Manufacturing
|
| O: -0.1%
H: 0.35%
C: -0.09%
VTRS | News A | $11.29 -0.62% 580K
|
Health Technology
|
| O: -5.01%
H: 0.0%
C: 0.0%
NVS | News | $98.03 0.77% 650K
|
Health Technology
|
| O: -0.67%
H: 0.0%
C: 0.0%
JNJ | News | $147.885 -1.12% 1.5M
|
Health Technology
|
| O: 0.01%
H: 0.0%
C: 0.0%
GSK | News | $40.82 -1.02% 230K
|
Health Technology
|
| O: -1.57%
H: 1.5%
C: 1.39%
BSX | $73.875 7.08% 3.7M
|
Health Technology
|
| O: -4.95%
H: 2.32%
C: 1.9%
BHC | $8.53 100K
|
Health Technology
|
| O: -3.12%
H: 0.37%
C: 0.19%
ABBV | News | $168.635 -0.53% 440K
|
Health Technology
|
| O: -2.17%
H: 0.0%
C: 0.0%
SNY | News | $47.1 -1.24% 260K
|
Health Technology
|
| O: -2.01%
H: 0.0%
C: 0.0%
NMRD | $0.06 120K
|
Health Technology
|
| O: 17.02%
H: 0.52%
C: -2.6%
AMGN | News | $273.905 0.13% 270K
|
Health Technology
|
| O: -1.38%
H: 0.65%
C: 0.46%
device disease
HealthTab™ to Offer Abbott’s i-STAT Alinity™, Expanding Chronic Disease Testing to Select Community Pharmacies in Canada
Published: 2021-11-23 (Crawled : 13:00) - globenewswire.com
AVCRF | $0.1056 500
|
Health Technology
|
| O: -3.3%
H: 0.0%
C: 0.0%
disease test
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
CZOO | $11.44 129.26% 4.6M
|
AMST | $3.4 70.0% 51M
|
Technology Services
BOF | $1.78 52.14% 15M
|
CSSE 4 | $0.23 51.02% 46M
|
Consumer Services
RILY | $30.87 42.13% 7.8M
|
Finance
LICN | $0.76 35.71% 6.2M
|
TROO | $1.41 29.36% 280K
|
Manufacturing
MULN | News | $3.53 29.3% 4.8M
|
Information
RBBN 4 | $3.26 26.85% 1.2M
|
Electronic Technology
RCAT | $1.52 26.67% 1.3M
|
Information
Your saved searches
Save your searches and get alerts when important news are released.